Use of MRI-based deep learning radiomics to diagnose sacroiliitis related to axial spondyloarthritis

The role of deep learning in diagnostic imaging of spondyloarthropathies: a systematic review

AIM

Diagnostic imaging is an integral part of identifying spondyloarthropathies (SpA), yet the interpretation of these images can be challenging. This review evaluated the use of deep learning models to enhance the diagnostic accuracy of SpA imaging.

METHODS

Following PRISMA guidelines, we systematically searched major databases up to February 2024, focusing on studies that applied deep learning to SpA imaging. Performance metrics, model types, and diagnostic tasks were extracted and analyzed. Study quality was assessed using QUADAS-2.

RESULTS

We analyzed 21 studies employing deep learning in SpA imaging diagnosis across MRI, CT, and X-ray modalities. These models, particularly advanced CNNs and U-Nets, demonstrated high accuracy in diagnosing SpA, differentiating arthritis forms, and assessing disease progression. Performance metrics frequently surpassed traditional methods, with some models achieving AUCs up to 0.98 and matching expert radiologist performance.

CONCLUSION

This systematic review underscores the effectiveness of deep learning in SpA imaging diagnostics across MRI, CT, and X-ray modalities. The studies reviewed demonstrated high diagnostic accuracy. However, the presence of small sample sizes in some studies highlights the need for more extensive datasets and further prospective and external validation to enhance the generalizability of these AI models.

KEY POINTS

Question How can deep learning models improve diagnostic accuracy in imaging for spondyloarthropathies (SpA), addressing challenges in early detection and differentiation from other forms of arthritis? Findings Deep learning models, especially CNNs and U-Nets, showed high accuracy in SpA imaging across MRI, CT, and X-ray, often matching or surpassing expert radiologists. Clinical relevance Deep learning models can enhance diagnostic precision in SpA imaging, potentially reducing diagnostic delays and improving treatment decisions, but further validation on larger datasets is required for clinical integration.

Update of imaging in the assessment of axial spondyloarthritis

This update addresses new developments in imaging of axial spondyloarthritis from the past 5 years. These have focused mostly on enhanced CT and MRI-based technologies that bring greater precision to the assessment of both inflammatory and structural lesions in the sacroiliac joint. An international consensus has recommended a 4-sequence MRI for routine diagnostic evaluation of the sacroiliac joint aimed at depicting the location and extent of inflammation as well as an erosion-sensitive sequence for structural damage. The latter include high resolution thin slice sequences that accentuate the interface between subchondral bone and the overlying cartilage and joint space as well as synthetic CT, a deep learning-based technique that transforms certain MRI sequences into images resembling CT. Algorithms based on deep learning derived from plain radiographic, CT, and MRI datasets are increasingly more accurate at identifying sacroiliitis and individual lesions observed on images of the sacroiliac joints and spine.

Deep learning analysis for rheumatologic imaging: current trends, future directions, and the role of human

Rheumatic diseases, such as rheumatoid arthritis (RA), osteoarthritis (OA), and spondyloarthritis (SpA), present diagnostic and management challenges due to their impact on connective tissues and the musculoskeletal system. Traditional imaging techniques, including plain radiography, ultrasounds, computed tomography, and magnetic resonance imaging (MRI), play a critical role in diagnosing and monitoring these conditions, but face limitations like inter-observer variability and time-consuming assessments. Recently, deep learning (DL), a subset of artificial intelligence, has emerged as a promising tool for enhancing medical imaging analysis. Convolutional neural networks, a DL model type, have shown great potential in medical image classification, segmentation, and anomaly detection, often surpassing human performance in tasks like tumor identification and disease severity grading. In rheumatology, DL models have been applied to plain radiography, ultrasounds, and MRI for assessing joint damage, synovial inflammation, and disease progression in RA, OA, and SpA patients. Despite the promise of DL, challenges such as data bias, limited explainability, and the need for large annotated datasets remain significant barriers to its widespread adoption. Furthermore, human oversight and value judgment are essential for ensuring the ethical use and effective implementation of DL in clinical settings. This review provides a comprehensive overview of DL's applications in rheumatologic imaging and explores its future potential in enhancing diagnosis, treatment decisions, and personalized medicine.

Deep-Learning-Based Radiomics to Predict Surgical Risk Factors for Lumbar Disc Herniation in Young Patients: A Multicenter Study

Objective

The aim of this study is to develop and validate a deep-learning radiomics model for predicting surgical risk factors for lumbar disc herniation (LDH) in young patients to assist clinicians in identifying surgical candidates, alleviating symptoms, and improving prognosis.

Methods

A retrospective analysis of patients from two medical centers was conducted. From sagittal and axial MR images, the regions of interest were handcrafted to extract radiomics features. Various machine-learning algorithms were employed and combined with clinical features, resulting in the development of a deep-learning radiomics nomogram (DLRN) to predict surgical risk factors for LDH in young adults. The efficacy of the different models and the clinical benefits of the model were compared.

Results

We derived six sets of features, including clinical features, radiomics features (Rad_SAG and Rad_AXI) and deep learning features (DL_SAG and DL_AXI) from sagittal and axial MR images, as well as fused deep-learning radiomics (DLR) features. The support vector machine(SVM) algorithm exhibited the best performance. The area under the curve (AUC) of DLR in the training and testing cohorts of 0.991 and 0.939, respectively, were significantly better than those of the models developed with radiomics(Rad_SAG=0.914 and 0.863, Rad_AXI=0.927 and 0.85) and deep-learning features(DL_SAG=0.959 and 0.818, DL_AXI=0.960 and 0.811). The AUC of DLRN coupled with clinical features(ODI, Pfirrmann grade, SLRT, MMFI, and MSU classification) were 0.994 and 0.941 in the training and testing cohorts, respectively. Analysis of the calibration and decision curves demonstrated good agreement between the predicted and observed outcomes, and the use of the DLRN to predict the need for surgical treatment of LDH demonstrated significant clinical benefits.

Conclusion

The DLRN established based on clinical and DLR features effectively predicts surgical risk factors for LDH in young adults, offering valuable insights for diagnosis and treatment.

Artificial intelligence and machine learning in axial spondyloarthritis

PURPOSE OF REVIEW

To evaluate the current applications and prospects of artificial intelligence and machine learning in diagnosing and managing axial spondyloarthritis (axSpA), focusing on their role in medical imaging, predictive modelling, and patient monitoring.

RECENT FINDINGS

Artificial intelligence, particularly deep learning, is showing promise in diagnosing axSpA assisting with X-ray, computed tomography (CT) and MRI analyses, with some models matching or outperforming radiologists in detecting sacroiliitis and markers. Moreover, it is increasingly being used in predictive modelling of disease progression and personalized treatment, and could aid risk assessment, treatment response and clinical subtype identification. Variable study designs, sample sizes and the predominance of retrospective, single-centre studies still limit the generalizability of results.

SUMMARY

Artificial intelligence technologies have significant potential to advance the diagnosis and treatment of axSpA, providing more accurate, efficient and personalized healthcare solutions. However, their integration into clinical practice requires rigorous validation, ethical and legal considerations, and comprehensive training for healthcare professionals. Future advances in artificial intelligence could complement clinical expertise and improve patient care through improved diagnostic accuracy and tailored therapeutic strategies, but the challenge remains to ensure that these technologies are validated in prospective multicentre trials and ethically integrated into patient care.